Overview of Cleaning Validation in Pharmaceutical Industry
Abstract
Manufacturing of Pharmaceutical drug products and drug substances shall demonstrate a control to reproduce consistently the desired quality of product, wherein the control of cross-contamination plays an important roll. Residual materials from the previous batch of the same product or from different product may be carried to the next batch of the product, which in-turn may alter the impurity profile of the subjected product. An effective cleaning shall be in place to provide documented evidence that the cleaning methods employed within a facility consistently controls potential carryover of product (including intermediates and impurities), cleaning agents and extraneous material into subsequent product to a level which is below predetermined levels.Keywords:
Contamination, cleaning validation, residue, levels of cleaningReferences
1. ICH Q7: ICH Harmonised Tripartite Guideline: Good manufacturing practice guide for active pharmaceutical ingredients: Current Step 4 version; dated 10 2000.
2. Alcock, P. and Motise, P.FDA statement: Human Drug cGMP Notes.
3. APIC: Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants: 1999; 3-7.
4. APIC: Guidance on aspects of cleaning validation in active pharmaceutical ingredient plants; 2000; 16-19.
5. US FDA: Guide to inspections validation of cleaning processes.
6. Gil Bismuth and Shosh Neumann, "Cleaning Validation: A Practical Approach," Interpharm Press, 2000.
7. Code of Federal Regulations Title 21, Volume 4, Section 211.67, 2006.
Published
2025-01-01
Statistics
Abstract Display: 0
PDF Downloads: 0 Issue
Section
Articles